NASDAQ:COO

CooperVision to host 3rd APAC Myopia Management Symposium in Taiwan Region

Held in partnership with Universal Eye Center, the hybrid event is expected to hostmore than 2,000 renowned Myopia Management experts across APAC and globally SINGAPORE, Nov. 24, 2023 /PRNewswire/ -- CooperVision , a global leader in myopia management, will host it...

2023-11-24 14:25 2124

Week's Top Stories

Most Reposted

VentureBlick Launches 'Discovery': The First Global Networking Platform for Healthcare Innovation

[Picked up by 319 media titles]

2024-05-08 14:37
VentureBlick Launches 'Discovery': The First Global Networking Platform for Healthcare Innovation

Multiple achievements made in China-Hungary BRI conference

[Picked up by 319 media titles]

2024-05-03 06:59
Multiple achievements made in China-Hungary BRI conference

Shanghai Jiao Tong University Offers Free Online Courses for International Learners, Joint Programs with Tmall of Alibaba and Dow Gain High Popularity

[Picked up by 318 media titles]

2024-05-07 08:00
Shanghai Jiao Tong University Offers Free Online Courses for International Learners, Joint Programs with Tmall of Alibaba and Dow Gain High Popularity

OPTIX raises US$15 million fundraising to date to solve the bottleneck of XR optics technology

[Picked up by 310 media titles]

2024-05-08 08:00

IN2MF in Kuala Lumpur Presented by Bank Indonesia

[Picked up by 296 media titles]

2024-05-08 16:44
IN2MF in Kuala Lumpur Presented by Bank Indonesia

Most Read

/C O R R E C T I O N -- Addverb/

2024-05-03 20:26 15061
/C O R R E C T I O N -- Addverb/

Multiple achievements made in China-Hungary BRI conference

2024-05-03 06:59 10501
Multiple achievements made in China-Hungary BRI conference

Xinhua president, Hungarian economy minister vow to bolster media cooperation

2024-05-03 06:25 9876

Hang Seng Insurance Introduces FortuneLife Deferred Annuity Life Insurance Plan with Enhanced Benefit to Support Stable Retirement

2024-05-03 14:47 6633
Hang Seng Insurance Introduces FortuneLife Deferred Annuity Life Insurance Plan with Enhanced Benefit to Support Stable Retirement

Minghui Pharmaceutical to Present the Phase I/II Study of MHB088C (B7-H3 ADC) for the Treatment of Patients with Recurrent or Metastatic Solid Tumors in Late-breaking Oral Presentation at the 2024 ASCO Annual Meeting

2024-05-08 18:18 5214